CD80 and rheumatoid arthritis: However, this important result was anticipated by the demonstration that the inhibition of the CD80-CD86/CD28 co-stimulatory signaling pathway by CTLA4-Ig generally contributes to downregulate several pro-inflammatory mediators involved in the inflammatory cascade of RA (Table 1) (102–105).